Iovance grants inducement stock options for 179,750 shares at $10.02 each
Iovance Biotherapeutics granted inducement stock options covering 179,750 shares to 18 new, non-executive employees on Sept. 17, 2026. Options carry an exercise price of $10.02, set at the stock’s closing price on the grant date. Vesting runs over three years, with one-third on the first anniversary of the start date.